Fenwick represented Vitable, a platform that provides accessible and comprehensive primary care, in its $16 million Series A funding. The round was led by Cherryrock Capital, with participation from Newark Venture Partners, Citi Impact Fund, First Round Capital, Commerce Ventures, and Y Combinator.
Vitable will use the funds to expand their services to over 40 states and enhance their primary care and navigation capabilities. More information can be obtained from the company’s announcement.
The Fenwick transaction team was led by corporate partner Steve Levine and included associates Angelo Angelino and Ty Chung.